Company Profile
Celcuity Stock Price, News & Analysis
Company overview
Business overview
Celcuity is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Celcuity is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Celcuity follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Celcuity sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
CELC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Celcuity’s catalysts are gedatolisib and the next oncology data in breast cancer or other solid tumors. The market will focus on whether the PI3K / mTOR story can still be made convincing in clinic.
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.